iOmx Therapeutics AG is a company that provides Cancer, Pharmacy and Therapeutics, Cell and more. iOmx Therapeutics AG is headquartered in Germany Bayern. iOmx Therapeutics AG was founded in 2016. iOmx Therapeutics AG has a total of 77 patents and 1 literature
Related Topics
CancerPharmacy and TherapeuticsCellImmune resistanceHuman tumorMode of actionImmune checkpointT cellReceptor
visualizing technology portfolio of hot application areas and blank areas for iOmx Therapeutics AG
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for iOmx Therapeutics AG
Sign up to view the full data
Free Trial Now
Download
iOmx Therapeutics AG Frequently Asked Questions
What technical fields has iOmx Therapeutics AG researched?
iOmx Therapeutics AG has researched the technical fields related toCancerPharmacy and TherapeuticsCellImmune resistanceHuman tumorMode of actionImmune checkpointT cellReceptor
What is iOmx Therapeutics AG's total number of patents?
iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoint modulators on tumor cells. By systematically...